Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allison, M. Genzyme backs Osiris, despite Prochymal flop. Nat Biotechnol 27, 966–967 (2009). https://doi.org/10.1038/nbt1109-966
Issue Date:
DOI: https://doi.org/10.1038/nbt1109-966
- Springer Nature America, Inc.
This article is cited by
-
Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease
Stem Cell Research & Therapy (2023)
-
A model study for the manufacture and validation of clinical-grade deciduous dental pulp stem cells for chronic liver fibrosis treatment
Stem Cell Research & Therapy (2020)
-
Interactions between mesenchymal stem cells and the immune system
Cellular and Molecular Life Sciences (2017)
-
Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis
Journal of Molecular Neuroscience (2016)
-
Challenges in the translation and commercialization of cell therapies
BMC Biotechnology (2015)